Skip to content

Clover Health Investments CLOV Proceeds from sales of short-term investments and available-for-sale securities

Proceeds from sales of short-term investments and available-for-sale securities at other companies

SiriusPoint logo
SiriusPointSPNT
$11M-90.9%
Air Products and Chemicals logo
Air Products and ChemicalsAPD
$0-100%
BILL Holdings logo
BILL HoldingsBILL
$465.88M-25.4%
Tesla, Inc. logo
Tesla, Inc.TSLA
$0-100%
Varonis Systems logo
Varonis SystemsVRNS
$62.57M+83.1%
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$145K

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.67B-49.7%
P/S1.2×-2.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept clov:ProceedsFromSaleOfShortTermInvestmentsAndAvailableForSaleSecurities.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's proceeds from sales of short-term investments and available-for-sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clover Health Investments's proceeds from sales of short-term investments and available-for-sale securities?
Clover Health Investments (CLOV) reported proceeds from sales of short-term investments and available-for-sale securities of $33.84M in Q1 2026.
How has Clover Health Investments's proceeds from sales of short-term investments and available-for-sale securities changed year-over-year?
Clover Health Investments's proceeds from sales of short-term investments and available-for-sale securities increased by 105.3% year-over-year, from $16.48M to $33.84M.
What is the long-term trend for Clover Health Investments's proceeds from sales of short-term investments and available-for-sale securities?
Over 4 years (2021 to 2025), Clover Health Investments's proceeds from sales of short-term investments and available-for-sale securities has grown at a 9.9% compound annual growth rate (CAGR), from $126.86M to $185.16M.
What does proceeds from sales of short-term investments and available-for-sale securities mean?
This metric reports the cash inflows generated from the voluntary sale of short-term investment securities before their maturity date. It reflects the company's ability to liquidate assets to generate cash for operations or other capital needs. High activity here indicates active treasury management and liquidity optimization.